Literature DB >> 24404849

How to determine the size of folding nuclei of protofibrils from the concentration dependence of the rate and lag-time of aggregation. I. Modeling the amyloid protofibril formation.

Nikita V Dovidchenko1, Alexey V Finkelstein, Oxana V Galzitskaya.   

Abstract

The question about the size of nuclei of formation of protofibrils (which constitute mature amyloid fibrils) formed by different proteins and peptides is yet open and debatable because of the absence of solid knowledge of underlying mechanisms of amyloid formation. In this work, a kinetic model of the process of formation of amyloid protofibrils is suggested, which allows calculation of the size of the nuclei using only kinetic data. In addition to the stage of primary nucleation, which is believed to be present in many protein aggregation processes, the given model includes both linear growth of protofibrils (proceeding only at the cost of attaching of monomers to the ends) and exponential growth of protofibrils at the cost of growth from the surface, branching, and fragmentation with the secondary nuclei. Theoretically, only the exponential growth is compatible with the existence of a pronounced lag-period (which can take much more time then the growth of aggregates themselves). The obtained analytical solution allows us to determine the size of the primary and secondary nuclei from the experimentally obtained concentration dependences of the time of growth and the new parameter-the ratio Lrel of the lag-time duration to the time of growth of amyloid protofibrils.

Mesh:

Substances:

Year:  2014        PMID: 24404849     DOI: 10.1021/jp4083294

Source DB:  PubMed          Journal:  J Phys Chem B        ISSN: 1520-5207            Impact factor:   2.991


  7 in total

Review 1.  Molecular interactions of amyloid nanofibrils with biological aggregation modifiers: implications for cytotoxicity mechanisms and biomaterial design.

Authors:  Durga Dharmadana; Nicholas P Reynolds; Charlotte E Conn; Céline Valéry
Journal:  Interface Focus       Date:  2017-06-16       Impact factor: 3.906

2.  Critical Nucleus Structure and Aggregation Mechanism of the C-terminal Fragment of Copper-Zinc Superoxide Dismutase Protein.

Authors:  Yu Zou; Yunxiang Sun; Yuzhen Zhu; Buyong Ma; Ruth Nussinov; Qingwen Zhang
Journal:  ACS Chem Neurosci       Date:  2016-02-10       Impact factor: 4.418

3.  The Kinetics of Amyloid Fibril Formation by de Novo Protein Albebetin and Its Mutant Variants.

Authors:  Vitalii Balobanov; Rita Chertkova; Anna Egorova; Dmitry Dolgikh; Valentina Bychkova; Mikhail Kirpichnikov
Journal:  Biomolecules       Date:  2020-02-05

Review 4.  Life in Phases: Intra- and Inter- Molecular Phase Transitions in Protein Solutions.

Authors:  Vladimir N Uversky; Alexei V Finkelstein
Journal:  Biomolecules       Date:  2019-12-08

Review 5.  MIRRAGGE - Minimum Information Required for Reproducible AGGregation Experiments.

Authors:  Pedro M Martins; Susanna Navarro; Alexandra Silva; Maria F Pinto; Zsuzsa Sárkány; Francisco Figueiredo; Pedro José Barbosa Pereira; Francisca Pinheiro; Zuzana Bednarikova; Michał Burdukiewicz; Oxana V Galzitskaya; Zuzana Gazova; Cláudio M Gomes; Annalisa Pastore; Louise C Serpell; Rostislav Skrabana; Vytautas Smirnovas; Mantas Ziaunys; Daniel E Otzen; Salvador Ventura; Sandra Macedo-Ribeiro
Journal:  Front Mol Neurosci       Date:  2020-11-27       Impact factor: 5.639

6.  Smooth muscle titin forms in vitro amyloid aggregates.

Authors:  Alexandr G Bobylev; Oxana V Galzitskaya; Roman S Fadeev; Liya G Bobyleva; Darya A Yurshenas; Nikolay V Molochkov; Nikita V Dovidchenko; Olga M Selivanova; Nikita V Penkov; Zoya A Podlubnaya; Ivan M Vikhlyantsev
Journal:  Biosci Rep       Date:  2016-05-20       Impact factor: 3.840

7.  Should the Treatment of Amyloidosis Be Personified? Molecular Mechanism of Amyloid Formation by Aβ Peptide and Its Fragments.

Authors:  Oxana V Galzitskaya; Alexey K Surin; Anna V Glyakina; Vadim V Rogachevsky; Olga M Selivanova
Journal:  J Alzheimers Dis Rep       Date:  2018-10-24
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.